Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

Abstract

The organic cation transporter 1, encoded by the SLC22A1 gene, is responsible for the uptake of the anti-hyperglycaemic drug, metformin, in the hepatocyte. We assessed whether a genetic variation in the SLC22A1 gene is associated with the glucose-lowering effect of metformin. Incident metformin users in the Rotterdam Study, whose HbA1c measurements were available, were identified. Associations between 11 tagging single nucleotide polymorphisms in the SLC22A1 gene and change in the HbA1c level were analyzed. A total of 102 incident metformin users were included in this study sample. Except for the rs622342 A>C polymorphism, no significant differences in metformin response were observed. For each minor C allele at rs622342, the reduction in HbA1c levels was 0.28% less (95% CI 0.09–0.47, P=0.005). After Bonferroni correction, the P-value was 0.050. To conclude, genetic variation at rs622342 in the SLC22A1 gene was associated with the glucose-lowering effect of metformin in patients with diabetes mellitus.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kirpichnikov D, McFarlane SI, Sowers JR . Metformin: an update. Ann Intern Med 2002; 137: 25–33.

    Article  CAS  PubMed  Google Scholar 

  2. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000; 49: 2063–2069.

    Article  CAS  PubMed  Google Scholar 

  3. Borst SE, Snellen HG . Metformin, but not exercise training, increases insulin responsiveness in skeletal muscle of Sprague–Dawley rats. Life Sci 2001; 69: 1497–1507.

    Article  CAS  PubMed  Google Scholar 

  4. Takane H, Shikata E, Otsubo K, Higuchi S, Ieiri I . Polymorphism in human organic cation transporters and metformin action. Pharmacogenomics 2008; 9: 415–422.

    Article  CAS  PubMed  Google Scholar 

  5. Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 2007; 117: 1422–1431.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, Sugiyama Y . Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther 2002; 302: 510–515.

    Article  CAS  PubMed  Google Scholar 

  7. Wang DS, Kusuhara H, Kato Y, Jonker JW, Schinkel AH, Sugiyama Y . Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol 2003; 63: 844–848.

    Article  CAS  PubMed  Google Scholar 

  8. The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789–796.

    Article  Google Scholar 

  9. Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 2003; 100: 5902–5907.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP et al. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther 2008; 83: 273–280.

    Article  CAS  PubMed  Google Scholar 

  11. Shikata E, Yamamoto R, Takane H, Shigemasa C, Ikeda T, Otsubo K et al. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin. J Hum Genet 2007; 52: 117–122.

    Article  CAS  PubMed  Google Scholar 

  12. Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol 2007; 22: 819–829.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA . Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403–422.

    Article  CAS  PubMed  Google Scholar 

  14. Complete ATC index 2008. WHO Collaborating Centre for Drug Statistics Methodology. Web site. Available from: URL: http://www.whocc.no/atcddd/indexdatabase/ Accessed June 20, 2008.

  15. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008; 31 (Suppl 1): S12–54.

  16. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008; 371: 1505–1512.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Sentrix HumanHap550 Genotyping Beadchip. Illumina Inc. Web site. Available from: URL: http://www.illumina.com/downloads/HUMANHAP550_DataSheet.pdf. Accessed June 20, 2008.

  18. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA . Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106–120.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Drs JJ Lous for making the STAR–MDC data available for our study and F Rivadeneira, PP Arp and M Jhamai for help with providing the genotyping data.

This study was supported by The Netherlands Organisation for Scientific Research (NWO) (175.01.2005.011) and by The Netherlands Genomics Initiative (NGI) (050-060-810).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B H C Stricker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Becker, M., Visser, L., van Schaik, R. et al. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J 9, 242–247 (2009). https://doi.org/10.1038/tpj.2009.15

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2009.15

Keywords

This article is cited by

Search

Quick links